OR WAIT 15 SECS
November 19, 2020
Gut bacteria may be partially responsible for metabolic changes that lead to weight gain following chemotherapy treatment, according to a recent study.
November 17, 2020
The phase 1b clinical trial combined olaparib with capivasertib to treat patients with germline BRCA1/2 mutations and BRCA1/2 wild-type cancers.
The FDA approved Merck's blockbuster cancer drug, pembrolizumab (Keytruda), in combination with chemotherapy, to treat locally recurrent unresectable or metastatic triple-negative breast cancer.
November 16, 2020
How community pharmacists can advance care as patients come home.
November 10, 2020
Pharmacists-in-training have a valuable impact on cancer care, according to authors of a recent journal article.
Many opportunities exist for pharmacists within the multidisciplinary care team to ensure the delivery of optimal cancer care.
October 13, 2020
The rate of prescribing opioids among both oncologists and non-oncologists has dropped significantly in the past few years.
October 12, 2020
Pharmacists are uniquely qualified to ensure patients receive sufficient pain relief.
October 05, 2020
Nivolumab plus ipilimumab decreased tumor growth in patients with untreated unresectable malignant pleural mesothelioma.
New policy recommendations aim to increase the uptake of biomarker testing and advance health insurance coverage for precision medicine in cancer care.
